Effectiveness of Cotreatment with Kuntai Capsule and Climen for Premature Ovarian Failure: A Meta-Analysis

Qianwen Ma; Yong Tan; Genlin Mo

doi:10.1155/2020/4367359

Effectiveness of Cotreatment with Kuntai Capsule and Climen for Premature Ovarian Failure: A Meta-Analysis

Evid Based Complement Alternat Med. 2020 Feb 19:2020:4367359. doi: 10.1155/2020/4367359. eCollection 2020.

Authors

Qianwen Ma^{1

2}, Yong Tan², Genlin Mo³

Affiliations

¹ Gynecology Department, Zhenjiang Hospital Affiliated to Nanjing University of Chinese Medicine (Zhenjiang Hospital of Traditional Chinese Medicine), Zhenjiang, China.
² Reproductive Medicine Department, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.
³ Advanced Manufacturing Institution, Jiangsu University, Zhenjiang, China.

Abstract

Objective: To compare the treatment efficacy of Kuntai capsule with Climen only in the therapy of premature ovarian failure.

Methods: Randomized controlled trials were electronically retrieved from PubMed, Cochrane Library, Web of science, CBM, CNKI, Wanfang, and Weipu database. In addition, some related papers were manually checked. All papers were assessed according to the Cochrane Handbook for Systematic Reviews of Interventions, and the effective data were analyzed by Revman 5.3 Software.

Results: 11 randomized control trials involving 1068 patients were included. Results of meta-analysis showed that E₂ (estrogen), the total therapeutic effective rate of the group of Kuntai capsule, and hormone were higher than hormone only. The LH (luteinizing hormone), FSH (follicle-stimulating hormone), and Kupperman score of the group of Kuntai capsule and Climen were lower than Climen only.

Conclusion: Available evidence shows that Kuntai capsule with Climen is more effective than Climen in the therapy of premature ovarian failure. Nowadays, the quality of the research studies is low. More large-scaled randomized trials will need to be carried out.

Publication types

Review